marijuana stock news

Chuma Holdings, Inc. (CHUM)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Feb 28, 2015 Nov 30, 2014 Aug 31, 2014 May 31, 2014
Total Revenue 64   67   34   –  
Cost of Revenue
Gross Profit 64   67   34   –  
Operating Expenses
Research Development
Selling General and Administrative 115 1,017 497 133
Non Recurring 4,014 22
Others 0 0 0 0
Total Operating Expenses
Operating Income or Loss (4,065) (972) (464) (133)
Income from Continuing Operations
Total Other Income/Expenses Net 518 12
Earnings Before Interest And Taxes (4,065) (454) (452) (133)
Interest Expense 7 7 8 8
Income Before Tax (4,071) (461) (459) (140)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (4,071) (461) (459) (140)
Non-recurring Events
Discontinued Operations (2)
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (4,071) (461) (459) (143)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (4,071) (461) (459) (143)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cresco Labs (CRLBF) Expands Sunnyside in Florida’s Gulf Coast With New Clearwater Dispensary

Cresco Labs Expands Sunnyside in Florida’s Gulf Coast With New Clearwater Dispensary…

Village Farms International, Inc. (VFF) Takes Top Honors at the 2025 Stevie® Awards

Village Farms International Takes Top Honors at the 2025 Stevie® Awards Village…

$SING Opportunities High Amid Congressional Call for Cannabis Banking Reform

SinglePoint Subsidiary: Opportunities High Amid Congressional Call for Cannabis Banking Reform SinglePoint,…

GW Pharmaceuticals plc (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex®

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex®…